Interferon-beta Theraphy in Multiple Sclerosis Patients: is Response Age Dependent?

Kurne A., TERZİ M., Aydin O. F., ONAR M. K., KARABUDAK R.

JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH, vol.26, no.2, pp.131-138, 2009 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 26 Issue: 2
  • Publication Date: 2009
  • Journal Name: JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.131-138
  • Hacettepe University Affiliated: Yes

Abstract

The onset of Multiple sclerosis (MS) is usually between 20 and 40 years and in those patients, beta-interferons reduce relapse frequency in a rate of 30%. The purpose of this study was to compare the therapeutical response to IFN beta in young versus older MS patients.